VeMiDoc, Inc

Telemedicine for the LatinX community.
Austin

About VeMiDoc, Inc

Telemedicine for the LatinX community.
1) VeMiDoc has developed a fully integrated and functional bilingual platform that connects patients to their own local and trusted doctors.
2) They have a strong network of medical providers and partnerships with a range of healthcare entities (ie, Managed Care Organizations) that are best placed to reach Latino patients.
3) VeMiDoc’s strength is not only in the proprietary platform and network, but in their targeted messaging strategy and outreach in Spanish.

Tagged with

Problem statement

Latinos are the fastest growing US population. They have the highest life expectancy rates, yet among the lowest rates of access to healthcare in the nation. This disparity is caused by lack of affordable options, coupled with socio-economic, language and cultural barriers when seeking out healthcare—a disproportionate effect that has been exacerbate. No telemedicine company has made a serious effort to capture it.

Traction information

Founded by two doctors
Product launched in El Paso - Chose El Paso because they have an 83% Latino population, have onboarded of El Paso health physicians
Secured contract with El Paso Health Inc., a local managed care org (mco) with over 1,300 network providers
Secured contract with El Paso Children’s Hospital, a local hospital with roughly 300 providers
Have the potential to expand to 2,500 additional providers via these existing agreements.
Recently entered discussions with an El Paso county hospital, a major managed care organization in Houston, and with a major hospital system in Santa Fe, NM.
In the running for a mental health grant through the Paso del Norte Foundation that will give access to dozens of mental health providers.
Accelerator Program - Medical Center of Americas, Innovation Center Program (El Paso, Texas)
Revenue for 2020 is $75,000.

Updates

Profile created.
Added over 4 years ago
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.